2014
Addressing the problem of ADHD medication as neuroenhancements
Graf W, Miller G, Nagel S. Addressing the problem of ADHD medication as neuroenhancements. Expert Review Of Neurotherapeutics 2014, 14: 569-581. PMID: 24738763, DOI: 10.1586/14737175.2014.908707.Peer-Reviewed Original ResearchConceptsADHD medicationNeurological disordersAttention deficit hyperactivity disorder (ADHD) diagnosisMedication overusePotent medicationsHealthy personsSubstance diversionMedicationsDisorder diagnosisNonmedical purposesDisordersIllegal diversionADHDOngoing scrutinyDiversionMethylphenidatePrevalenceDiagnosisPersonsAmphetamine
2013
Author Response.
Graf W, Nagel S, Osnabruck N, Epstein L, Miller G, Larriviere D. Author Response. Neurology 2013, 81: 1558-9. PMID: 24303531.Peer-Reviewed Original ResearchPediatric neuroenhancement
Rothman S, Graf W, Nagel S, Epstein L, Miller G, Larriviere D. Pediatric neuroenhancement. Neurology 2013, 81: 1558-1559. PMID: 24145884, DOI: 10.1212/01.wnl.0000437277.02794.3a.Peer-Reviewed Original ResearchPediatric neuroenhancement
Graf WD, Nagel SK, Epstein LG, Miller G, Nass R, Larriviere D. Pediatric neuroenhancement. Neurology 2013, 80: 1251-1260. PMID: 23486879, DOI: 10.1212/wnl.0b013e318289703b.Peer-Reviewed Original ResearchConceptsIndividual's decision-making capacityValue-laden practiceDecision-making capacityForms of coercionEthics issuesMoral obligationFiduciary obligationsDistributive justicePersonal authenticityAutonomous adolescentsFiduciary responsibilityNeuroenhancementVulnerability of childrenChild Neurology SocietyAmerican Neurological AssociationObligationsDiscussion pointsPosition paperAppropriate goalsIssuesNeurological AssociationEthicsMisuse of medicationsIntegrity issuesJustice
2009
Pediatric Bioethics
Miller G (Ed). Pediatric Bioethics. New York, Cambridge University Press, 2009 .Peer-Reviewed Original Research
2008
Futility by any other name.
Miller G. Futility by any other name. The Texas 10 day rule. Journal of Bioethical Inquiry 2008; 5: 265-270Peer-Reviewed Original ResearchFutility revisited. Reply to Mark Mercurio.
Miller G. Futility revisited. Reply to Mark Mercurio. Hastings Center Report 2008; Jan-Feb: 7Peer-Reviewed Original Research
2007
Myelination as Assessed by Conventional MR Imaging is Normal in Young Children with Idiopathic Developmental Delay
Maricich SM, Azizi P, Jones JY, Morriss MC, Hunter JV, Smith EO, Miller G. Myelination as Assessed by Conventional MR Imaging is Normal in Young Children with Idiopathic Developmental Delay. American Journal Of Neuroradiology 2007, 28: 1602-1605. PMID: 17846220, PMCID: PMC8134387, DOI: 10.3174/ajnr.a0602.Peer-Reviewed Original ResearchConceptsSubcortical U-fibersExtent of myelinationDevelopmental quotientBrain MRU-fibersWhite matterBrain regionsSubcortical myelinationIDD groupConventional brain MRBasis of historyYoung childrenConventional MR imagingMyelination scoreClinical historyPediatric neuroradiologistsIntracranial lesionsParietal lobeAxial T2Idiopathic developmental delayPsychomotor retardationScoring systemClear causePsychometric testingMyelinationLesion regression.
Airewele G, Miller G, McCluggage C, Chintagumpala M. Lesion regression. Journal Of Neurosurgery 2007, 107: 80-1; author reply 81. PMID: 17644928, DOI: 10.3171/PED-07/07/080.Peer-Reviewed Original ResearchTen days in Texas.
Miller G. Ten days in Texas. The Hastings Center Report 2007, 37: 1 p following 56. PMID: 17844925.Peer-Reviewed Original ResearchExtreme Prematurity. Practices, Bioethics, and the Law
Miller G. Extreme Prematurity. Practices, Bioethics, and the Law. New York, Cambridge University Press, 2007Peer-Reviewed Original Research
2006
Functional and clinical characterization of a mutation in KCNJ2 associated with Andersen-Tawil syndrome.
Lu CW, Lin JH, Rajawat YS, Jerng H, Rami TG, Sanchez X, DeFreitas G, Carabello B, DeMayo F, Kearney DL, Miller G, Li H, Pfaffinger PJ, Bowles NE, Khoury DS, Towbin JA. Functional and clinical characterization of a mutation in KCNJ2 associated with Andersen-Tawil syndrome. Journal Of Medical Genetics 2006, 43: 653-9. PMID: 16571646, PMCID: PMC2564587, DOI: 10.1136/jmg.2006.040816.Peer-Reviewed Original Research
2005
Cerebral folate deficiency with developmental delay, autism, and response to folinic acid.
Moretti P, Sahoo T, Hyland K, Bottiglieri T, Peters S, del Gaudio D, Roa B, Curry S, Zhu H, Finnell RH, Neul JL, Ramaekers VT, Blau N, Bacino CA, Miller G, Scaglia F. Cerebral folate deficiency with developmental delay, autism, and response to folinic acid. Neurology 2005, 64: 1088-90. PMID: 15781839, DOI: 10.1212/01.WNL.0000154641.08211.B7.Peer-Reviewed Original Research
1998
Cerebral Palsies Causes, Consequences, and Management
Miller G, Clark GD (Eds): Cerebral Palsies Causes, Consequences, and Management. Boston, Butterworth and Heinemann, 1998Peer-Reviewed Original Research
1992
tatic Encephalopathies of Infancy and Childhood
Miller G, Ramer JC (Eds): Static Encephalopathies of Infancy and Childhood. Raven Press, New York, 1992.Peer-Reviewed Original Research